Peptide MD, end-to-end.
From signal intake to endpoint reveal, every transition is graded, gated, and attested. The verifier replays the chain in your browser. The cryptography is the compliance.
XTL pipeline
Signal intake
11 connectors + 3 wearable feeds
Novelty composite
3-axis score per candidate
Thesis generation
12-agent swarm · 13 pools
Scenario planning
3-scenario probability set
Dossier export
7-rule gate · 8 audiences
Endpoint evaluation
OEA pre-reg + reveal
Agent swarm - 12 agents across 12 pools
Peptide MD runs a 12-agent set with full trace transparency. Every tool call, citation count, and grade is exposed in the agent inspector. Below is a real run.
Watch the swarm run
The trace is deterministic - the same query against the same indexed corpus replays the same agents in the same order with the same grades. Press Start to play this real run back at compressed wall-clock.
run-2026-04-27-0942Full step-by-step trace
Identify peptide candidates with strong RWE for tendon recovery, post-surgical, with grade B+ evidence ceiling
- 1intake-1pool · signal-intakepubmed.search({"q":"BPC-157 tendon recovery","limit":50})
Retrieved 38 records from PubMed. 12 RCT, 18 preclinical, 8 review. Indexed with novelty scores.
Grade B2140 ms38 cites - 2intake-2pool · signal-intakebiorxiv.search({"q":"TB-500 angiogenesis","limit":25})
Retrieved 14 preprints. 9 with code/data availability statement. 3 with replication data.
Grade C1780 ms14 cites - 3novelty-1pool · noveltynovelty.composite({"ids":["bpc-157","tb-500"]})
Composite novelty: BPC-157 = 0.41 (saturated literature), TB-500 = 0.62 (active preclinical, sparse RWE).
Grade B410 ms - 4biogate-1pool · biosecuritybiogate.scan({"sequences":["GEPPPGKPADDAGLV","LKKTETQ"]})
Both sequences pass GREEN tier. No 8-residue overlap with PoP-Shield-public toxin set.
Grade A320 ms - 5thesis-1pool · thesis
Drafted three-scenario thesis for BPC-157 + TB-500 combo: (1) safety-first single-agent compounding pathway, (2) combo investigational with structured cohort, (3) cosmetic adjacency repositioning. Each scenario tagged with required evidence grade and probability.
Grade B5840 ms12 cites - 6predcheck-1pool · predictionloo.posterior({"protocolSlug":"post-surgical-recovery"})
Living Outcome Oracle posterior for primary endpoint: Beta(α=22.4, β=11.8). P(Δ ROM > 10°) = 0.86. Reputation-adjusted weight = 0.71.
Grade B690 ms - 7export-gatepool · dossier
Buyer-safe dossier export gate evaluation: 7-rule check passed for compounding-pharmacy audience (Grade B citation present, biosec GREEN, jurisdiction-gated to allowed countries, RWE summary attached, prediction-outcome pairs disclosed, no human-use claims beyond cited indications, COA registry available). Dossier signed and committed to OEA-V1.
Grade B1120 ms4 cites
Two candidates qualify under the buyer-safe gate: BPC-157 (Grade B, multi-cohort RWE n=148, ROM Δ +14.2°) and TB-500 (Grade B, single-cohort RWE n=22, exploratory only). A combination protocol shows additive effect in cohort tendon-01 (current N=48). No safety signals above PoP-Shield threshold. Recommended dossier: Compounding-pharmacy ready for BPC-157; investigational-only for TB-500 monotherapy.
On-chain primitives
| Chain | Contract | Status |
|---|---|---|
| Solana | actor-registry | shipped |
| Solana | cohort-stake escrow | shipped |
| Solana | OEA registry | shipped |
| Solana | proof-of-cohort NFT | audit pending |
| Base | Molecule IPNFT V2 adapter | shipped |
| Base | royalty cascade | shipped |
Verification surface
@peptide-md/verifier
Pure-TypeScript verifier for PDA-V1 + OEA-V1. Web Crypto SubtleCrypto, no native deps. Live on npm.
Test vectors
Frozen cross-language test vectors. Three OEA vectors and three PDA vectors, all Peptide MD-issued.
Browser studio
The /verifier page is the same code path as the npm package. Tamper a byte, watch the verifier reject.